180 related articles for article (PubMed ID: 36292578)
1. Identification of a Hypomorphic
Meek K; Yang YT; Takada M; Parys M; Richter M; Engleberg AI; Thaiwong T; Griffin RL; Schall PZ; Kramer AJ; Yuzbasiyan-Gurkan V
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292578
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.
Thaiwong T; Sirivisoot S; Takada M; Yuzbasiyan-Gurkan V; Kiupel M
Vet Comp Oncol; 2018 Jun; 16(2):220-228. PubMed ID: 28929581
[TBL] [Abstract][Full Text] [Related]
3. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
4. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
5. A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype.
Shah R; van den Berk PCM; Pritchard CEJ; Song JY; Kreft M; Pilzecker B; Jacobs H
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446306
[TBL] [Abstract][Full Text] [Related]
6. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9.
Nakanishi K; Moran A; Hays T; Kuang Y; Fox E; Garneau D; Montes de Oca R; Grompe M; D'Andrea AD
Exp Hematol; 2001 Jul; 29(7):842-9. PubMed ID: 11438206
[TBL] [Abstract][Full Text] [Related]
8. FANCA and FANCG are the major Fanconi anemia genes in the Korean population.
Park J; Chung NG; Chae H; Kim M; Lee S; Kim Y; Lee JW; Cho B; Jeong DC; Park IY
Clin Genet; 2013 Sep; 84(3):271-5. PubMed ID: 23067021
[TBL] [Abstract][Full Text] [Related]
9. In silico study of missense variants of FANCA, FANCC and FANCG genes reveals high risk deleterious alleles predisposing to Fanconi anemia pathogenesis.
Shahid M; Azfaralariff A; Zubair M; Abdulkareem Najm A; Khalili N; Law D; Firasat S; Fazry S
Gene; 2022 Feb; 812():146104. PubMed ID: 34864095
[TBL] [Abstract][Full Text] [Related]
10. Founder haplotype analysis of Fanconi anemia in the Korean population finds common ancestral haplotypes for a FANCG variant.
Park J; Kim M; Jang W; Chae H; Kim Y; Chung NG; Lee JW; Cho B; Jeong DC; Park IY; Park MS
Ann Hum Genet; 2015 May; 79(3):153-61. PubMed ID: 25703136
[TBL] [Abstract][Full Text] [Related]
11. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9.
Yang Y; Kuang Y; Montes De Oca R; Hays T; Moreau L; Lu N; Seed B; D'Andrea AD
Blood; 2001 Dec; 98(12):3435-40. PubMed ID: 11719385
[TBL] [Abstract][Full Text] [Related]
13. Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in
Reyes P; García-de Teresa B; Juárez U; Pérez-Villatoro F; Fiesco-Roa MO; Rodríguez A; Molina B; Villarreal-Molina MT; Meléndez-Zajgla J; Carnevale A; Torres L; Frias S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216452
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two novel FANCG mutations in Indian Fanconi anemia patients.
Solanki A; Kumar Selvaa C; Sheth F; Radhakrishnan N; Kalra M; Vundinti BR
Leuk Res; 2017 Feb; 53():50-56. PubMed ID: 28024295
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
[TBL] [Abstract][Full Text] [Related]
17. Activating Mutations in
Takada M; Smyth LA; Thaiwong T; Richter M; Corner SM; Schall PZ; Kiupel M; Yuzbasiyan-Gurkan V
Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31277422
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study.
Auerbach AD; Greenbaum J; Pujara K; Batish SD; Bitencourt MA; Kokemohr I; Schneider H; Lobitzc S; Pasquini R; Giampietro PF; Hanenberg H; Levran O;
Hum Mutat; 2003 Feb; 21(2):158-68. PubMed ID: 12552564
[TBL] [Abstract][Full Text] [Related]
19. Clinical, cytogenetic and molecular findings in nine Moroccan patients with Fanconi anemia.
Doubaj Y; Zrhidri A; Elalaoui SC; Lyahyai J; El Kadiri Y; Elkassimi N; Sbiti A; El Kababri M; Hessissen L; Sefiani A
Pan Afr Med J; 2021; 39():72. PubMed ID: 34422195
[TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.
Yamamoto K; Ishiai M; Matsushita N; Arakawa H; Lamerdin JE; Buerstedde JM; Tanimoto M; Harada M; Thompson LH; Takata M
Mol Cell Biol; 2003 Aug; 23(15):5421-30. PubMed ID: 12861027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
